If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

Share Price is delayed by 15 minutes
Get Live Data
389.50    2.50 (0.65%)
Bid:
389.50
Ask:
391.00
Spread: 1.50 (0.385%)
Market Cap: £1.55b
PIN Live PriceLast checked at - London Stock Exchange

Intraday Pantheon International Share Chart

Monthly Performance Update

26 Feb 2019 07:00

RNS Number : 0640R
Pantheon International PLC
26 February 2019
 

26 February 2019

 

Pantheon International Plc

Performance Update at 31 January 2019

 

Highlights

 

2,551.1p NAV per share

-2.9% NAV per share growth for the month

£1.4bn Net asset value

£13.5m Net portfolio cash flow*

3.7x Financing cover**

+96% Total shareholder return (5Y)***

 

Month to 31 January 2019

 

PIP announced an unaudited net asset value ("NAV") per share at 31 January 2019 of 2,551.1p, a decrease of 75.9p (-2.9%) from the NAV per share as at 31 December 2018. Valuation gains* (4.3p, +0.2%), investment income* (0.7p, 0.0%) and share buybacks (0.3p, 0.0%) were offset by foreign exchange movements* (-78.7p, -3.0%) and expenses and taxes**** (-2.5p, -0.1%) during the period.

PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation as at 31 January 2019, all reported valuations are dated 30 September 2018 or later. A detailed description of PIP's valuation policy can be found on pages 92 and 93 of the 2018 Annual Report.

At 31 January 2019, PIP's private equity assets stood at £1,374m, whilst net available cash balances^ were £101m. The Asset Linked Note^^ ("ALN") outstanding as at 31 January 2019 amounted to £95m. Undrawn commitments to investments stood at £448m as at 31 January 2019, calculated using exchange rates at that date. PIP's multi-currency revolving credit facilities comprise a US$163.0m facility and a €59.8m facility, which remained undrawn at the month end.

 

PIP's portfolio generated net cash* of £13.5m during the month, with distributions of £17.9m relative to £4.4m of calls from existing commitments to private equity funds.

 

PIP made £7.5m of new commitments during the month comprising: a £5.0m secondary commitment to a European mid-market buyout fund, a £2.4m secondary direct commitment to a US music royalty company, and an initial investment alongside Madison India Capital in Star Health Insurance, the largest private health insurer in India.

 

 

 

 

Performance as at 31 January 2019^^^

 

1 Year

(%)

3 Years

(% pa)

5 Years

(% pa)

10 Years

(% pa)

Since Inception

(% pa)

NAV per share

18.7%

14.0%

14.3%

8.5%

11.7%

Ordinary share price

12.3%

19.2%

14.4%

24.1%

11.5%

FTSE All-Share TR

-3.8%

8.7%

5.6%

10.2%

7.7%

MSCI World (£) TR

1.6%

14.7%

12.4%

13.2%

7.8%

 

*Figures are stated net of movements associated with the ALN share of the reference portfolio.

 

**Ratio of net available cash, portfolio value and undrawn loan facility to outstanding commitments.

 

***Based on the change in the ordinary share price over the period.

 

****Withholding taxes on investment distributions.

 

^Net available cash calculated as cash and net current assets / (liabilities) less undistributed net cashflows associated with the ALN.

^^Unlisted 10-year note issued on 31 October 2017 whose cost and repayments are linked to a reference portfolio consisting of the Company's older vintage funds.

 

^^^PIP was launched on 18 September 1987. The performance figures for PIP assume reinvestment of dividends, capital repayments and cash flow from warrants.

 

Monthly Report

The January monthly newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters", or by following this link: http://www.piplc.com/investor-relations/newsletters.

 

 

Ends

 

 

 

 

LEI: 2138001B3CE5S5PEE928

 

For more information please visit PIP's website at www.piplc.com or contact:

 

Vicki Bradley

Pantheon

020 3356 1800

 

 

NOTES

PIP

PIP is a listed FTSE 250 private equity investment trust, overseen by an independent Board of Directors and managed by Pantheon, one of the leading investment managers globally. PIP offers a differentiated entry point to an investment company of scale with risk managed through selection and diversification, and to the excellent growth potential generated by some of the best private equity managers in the world.

 

Pantheon

Pantheon is a leading global private equity, infrastructure, real assets and debt fund investor that invests on behalf of over 510 investors. Founded in 1982, Pantheon has developed an established reputation in primary, co-investment and secondary private asset solutions across all stages and geographies. Pantheon has $42billion in AUM^^^^ (as at 30 September 2018) and 276 employees, including 81 investment professionals, located across offices in London, San Francisco, New York, Hong Kong, Seoul, Bogotá and Tokyo.

 

^^^^This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

 

Neither the contents of PIP's website nor the contents of any website accessible from hyperlinks on PIP's website (or any other website) is incorporated into, or forms part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEWFWIFUSEFE
Date   Source Headline
11th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
5th Jan 20247:00 amRNSMonthly Performance Update
2nd Jan 202411:32 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSMonthly Performance Update
1st Nov 202310:39 amRNSTotal Voting Rights
30th Oct 202312:53 pmRNSHolding(s) in Company
23rd Oct 202311:22 amRNSHolding(s) in Company
20th Oct 20237:00 amRNSMonthly Performance Update
19th Oct 20231:12 pmRNSResult of AGM
19th Oct 202310:00 amRNSCOMPLETION OF TENDER OFFER AND TOTAL VOTING RIGHTS
19th Oct 20237:00 amRNSRefinanced Credit Facility
18th Oct 20238:18 amRNSResult of Tender Offer
28th Sep 202312:06 pmRNSInvestor Presentation
25th Sep 20237:00 amRNSTender Offer
22nd Sep 20237:00 amRNSMonthly Performance Update
19th Sep 202312:41 pmRNSHolding(s) in Company
1st Sep 202312:16 pmRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSMonthly Performance Update
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
11th Aug 20234:00 pmRNSQuotedData's Weekly News & Interview
11th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20235:22 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSTransaction in Own Shares
9th Aug 202310:51 amRNSDirector/PDMR Shareholding
8th Aug 20232:54 pmRNSDirector/PDMR Shareholding
8th Aug 202311:59 amRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20235:22 pmRNSTransaction in Own Shares
4th Aug 20234:32 pmRNSDirector/PDMR Shareholding
4th Aug 20232:36 pmRNSDirector/PDMR Shareholding
3rd Aug 20234:37 pmRNSTransaction in Own Shares
3rd Aug 20233:44 pmRNSNotice of AGM
3rd Aug 202311:45 amRNSShare Buyback Programme
3rd Aug 20237:00 amRNSAnnual Financial Report
31st Jul 202312:54 pmRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.